Correlation Engine 2.0
Clear Search sequence regions


  • analysis data (1)
  • antivirals (6)
  • cases (1)
  • Conc (8)
  • coronavirus (1)
  • ebola virus (1)
  • egypt (3)
  • ethanol (17)
  • factors (4)
  • favipiravir (83)
  • Gilead (1)
  • hamster (1)
  • help (1)
  • human (14)
  • india (1)
  • japan (1)
  • lopinavir (1)
  • Low (1)
  • lungs (2)
  • merits (1)
  • methanol (3)
  • missouri (1)
  • patients (3)
  • ph 3 (1)
  • pH 4 (1)
  • pharmacy (1)
  • phosphoryl (1)
  • plasma (20)
  • plasma proteins (2)
  • powder (1)
  • prodrug (1)
  • quartz (1)
  • rapid (4)
  • reagents (1)
  • ritonavir (1)
  • rna (1)
  • rna polymerase (1)
  • rna virus (1)
  • RSD (2)
  • sars cov (4)
  • solutions (6)
  • solvent (10)
  • student (3)
  • tablets (8)
  • treatment protocol (2)
  • viral load (1)
  • viral rna (1)
  • Sizes of these terms reflect their relevance to your search.

    Remdesivir (REM) and Favipiravir (FAV) are recently approved antivirals prescribed in severely ill COVID-19 patients. Therefore, development of new, simple, rapid, sensitive, and selective methods for analysis of such drugs in their pharmaceutical formulations will be highly advantageous. Herein, we have developed different spectrophotometric methods for analysis of the studied analytes. Method I is based on direct spectrophotometric analysis of REM and FAV in ethanol at λmax 244 and 323 nm, respectively. For simultaneous quantitation of REM and FAV, methods II-V were followed. Method II is based on derivative spectrophotometry in which REM was determined in second-order derivative spectra at 248 nm (the zero-crossing wavelength for FAV), while FAV was measured in first-order derivative spectra at 337 nm (the zero-crossing point for REM). Method III is the dual-wavelength method in which spectral intensities were subtracted at 244-207 nm for REM and at 330-400 nm for FAV. Method IV is the ratio subtraction in which ratio spectra were obtained by a suitable divisor followed by subtraction of intensities at 272-340 nm and 335-222 nm for REM and FAV, respectively. Method V is the derivative ratio method in which the obtained ratio spectra in method IV were converted to first-order derivative and then REM and FAV were recorded at 280 and 340 nm, respectively. Calibration graphs were linear in the ranges of 1-10 µg/mL for REM through all methods and 1-20 µg/mL for FAV in methods I and II, and 2-20 µg/mL by the other methods. The evolved methods were applied to pharmaceutical dosage forms of REM and FAV. All the proposed methods were further applied to human plasma samples containing both drugs with acceptable mean recoveries. Copyright © 2022 Elsevier B.V. All rights reserved.

    Citation

    Heba Samir Elama, Abdallah M Zeid, Shereen Mahmoud Shalan, Yasser El-Shabrawy, Manal Ibrahim Eid. Eco-friendly spectrophotometric methods for determination of remdesivir and favipiravir; the recently approved antivirals for COVID-19 treatment. Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy. 2022 Nov 11;287(Pt 2):122070

    Expand section icon Mesh Tags

    Expand section icon Substances


    PMID: 36403556

    View Full Text